摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-Nitro-5-piperazin-4-ium-1-ylphenolate

中文名称
——
中文别名
——
英文名称
2-Nitro-5-piperazin-4-ium-1-ylphenolate
英文别名
——
2-Nitro-5-piperazin-4-ium-1-ylphenolate化学式
CAS
——
化学式
C10H13N3O3
mdl
——
分子量
223.232
InChiKey
XISMTXAQJGWFHU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.3
  • 重原子数:
    16
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    81.3
  • 氢给体数:
    2
  • 氢受体数:
    5

反应信息

  • 作为产物:
    参考文献:
    名称:
    Synthesis and magnetic relaxation properties of new Gd(III) complexes derived from DTPA-bis(amide) conjugates of arylpiperazinyl amines
    摘要:
    Two new Gd(III) complexes 1 and 2 of the type [Gd(L)H2O]center dot nH(2)O were synthesized from DTPA-bis(amide) conjugates of arylpiperazinyl amines. The relaxivity (R-1) of these complexes was measured in deionized water, which revealed that complex 2 had a higher relaxivity than land Omniscan, a commercially available MRI contrast agent. The cytotoxicity studies of 1 and 2 indicated that they are non-toxic which warrant their physiological suitability as potential contrast agents for MRI All the synthesized ligands and complexes were characterized with the aid of analytical and spectroscopic methods including elemental analysis, H-1 NMR, FT-IR, XPS and fast atom bombardment (FAB) mass spectrometry. (C) 2015 Elsevier B.V. All rights reserved.
    DOI:
    10.1016/j.inoche.2015.03.042
点击查看最新优质反应信息

文献信息

  • IMIDAZOPYRIDINE KINASE INHIBITORS
    申请人:GlaxoSmithKline LLC
    公开号:EP2162454B1
    公开(公告)日:2013-01-02
  • [EN] IMIDAZOPYRIDINE KINASE INHIBITORS<br/>[FR] INHIBITEURS D'IMIDAZOPYRIDINE KINASE
    申请人:SMITHKLINE BEECHAM CORP
    公开号:WO2008150799A1
    公开(公告)日:2008-12-11
    [EN] The present invention provides imidazopyridine compounds, compositions containing the same, as well as processes for the preparation and methods for their use as pharmaceutical agents. Formula (I).
    [FR] La présente invention propose des composés imidazopyridine, des compositions les contenant, ainsi que des processus de préparation et des procédés pour les utiliser en tant qu'agents pharmaceutiques.
查看更多